Discontinued — last reported Q3 '21

Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)

Non-Current Assets

Merck & Co. Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) increased by 65.2% to $3.80B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 65.2%, from $2.30B to $3.80B. Over 5 years (FY 2020 to FY 2025), Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) shows an upward trend with a 25.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ3 2021

How to read this metric

High amortization expenses reduce reported net income, though they are non-cash charges that do not impact operating cash flow.

Detailed definition

This is the projected expense for the upcoming year related to the systematic write-down of finite-lived intangible asse...

Peer comparison

Used to reconcile GAAP earnings with cash-based performance metrics across companies with heavy M&A activity.

Metric ID: finite_lived_intangible_assets_amortization_year_1

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$1.40B$1.50B$1.60B$2.30B$3.80B
QoQ Change—+7.1%+6.7%+43.8%+65.2%
YoY Change—+7.1%+6.7%+43.8%+65.2%
Range$1.40B – $3.80B
CAGR+171.4%
Avg YoY Growth+30.7%
Median YoY Growth+25.4%
Current Streak4+ quarters growth

Frequently Asked Questions

What is Merck & Co.'s finite-lived intangible assets - expected amortization expense (year one)?
Merck & Co. (MRK) reported finite-lived intangible assets - expected amortization expense (year one) of $3.80B in Q4 2025.
How has Merck & Co.'s finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?
Merck & Co.'s finite-lived intangible assets - expected amortization expense (year one) increased by 65.2% year-over-year, from $2.30B to $3.80B.
What is the long-term trend for Merck & Co.'s finite-lived intangible assets - expected amortization expense (year one)?
Over 5 years (2020 to 2025), Merck & Co.'s finite-lived intangible assets - expected amortization expense (year one) has grown at a 25.9% compound annual growth rate (CAGR), from $1.20B to $3.80B.
What does finite-lived intangible assets - expected amortization expense (year one) mean?
The expected accounting expense for writing down intangible assets over the next year.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.